Total Clarity Wealth Management, Inc. - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 26 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Total Clarity Wealth Management, Inc. ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q3 2021$4,000
-42.9%
6990.0%0.00%
-50.0%
Q1 2021$7,0006990.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q2 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 970,147$5,0540.28%
Gradient Capital Advisors, LLC 26,808$139,6700.06%
KRAEMATON INVESTMENT ADVISORS, INC 1,600$8,3360.01%
WEST PACES ADVISORS INC. 1,665$8,6750.00%
Tower Research Capital LLC (TRC) 2,432$130.00%
BANK OF MONTREAL /CAN/ 240,980$1,247,6600.00%
CIBC WORLD MARKET INC. 47,427$2510.00%
DIMENSIONAL FUND ADVISORS LP 27,661$1460.00%
BANK OF AMERICA CORP /DE/ 2,000$10,4200.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders